Navigating the stock market is like mastering a wooden frigate on the open sea during a hurricane. Frequently the ship must be captained through dangerous waters under a number of constant threats, from lightning to massive waves. Occasionally the ship may steer into the eye of the storm and be granted temporary quiescence.
Though in the days of wooden frigates it was difficult or impossible to predict how long the storm would last, where it would be most severe, and how one could exit safely, investors in today’s stock market have a number of helpful tools at their disposal, one of which is the stock catalyst calendar. For biotech stocks, catalysts can provide a material force in a sector whose successes otherwise seem to be dependent upon the whims of wall street bankers and retail investors.
We have compiled a calendar of upcoming catalysts for biotechnology stocks that are publicly-traded on the New York Stock Exchange and the NASDAQ Exchange, ranging from micro-cap to mega-cap. Many of the companies in our calendar are developing immunotherapies for cancer and other diseases. We have provided links to the relevant press release of each company, from which the catalysts are derived, and also to dedicated pages with technical analysis, news, and other information for many of the tickers. You can learn more about ImmunoBiotech companies and their upcoming catalysts on the ImmunoFrontiers ImmunoBiotech Viewspace. Note that the table can be sorted by clicking on headings and searched using the search bar.
Interested in investing? Receive $5 by signing up for Acorns.
Learn about the latest research in the fields of immunology and immuno-biotech.